JACC-Heart Failure

Scope & Guideline

Defining the Future of Cardiovascular Medicine

Introduction

Immerse yourself in the scholarly insights of JACC-Heart Failure with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2213-1779
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2013 to 2024
AbbreviationJACC-HEART FAIL / JACC-Heart Fail.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal 'JACC: Heart Failure' focuses on the advancement of knowledge in the field of heart failure through rigorous research and clinical insights. It emphasizes the importance of guideline-directed medical therapy, innovative treatment strategies, and the management of comorbid conditions associated with heart failure.
  1. Heart Failure Management Strategies:
    The journal covers clinical trials and studies focusing on the management of heart failure, including pharmacological interventions, device therapy, and rehabilitation approaches.
  2. Epidemiology and Risk Factors:
    Research on the epidemiology of heart failure, including the identification of risk factors, comorbidities, and social determinants of health that influence patient outcomes.
  3. Innovative Therapies and Technologies:
    Exploration of new therapeutic strategies, including the use of sodium-glucose cotransporter inhibitors, novel devices, and digital health technologies for heart failure management.
  4. Patient-Centered Care:
    Emphasis on the importance of patient-reported outcomes, quality of life assessments, and the integration of patient preferences in heart failure treatment plans.
  5. Guideline-Directed Medical Therapy (GDMT):
    Studies focusing on the implementation, adherence, and optimization of GDMT in diverse populations, including challenges faced in clinical practice.
  6. Health Disparities in Heart Failure:
    Investigation into disparities in heart failure care and outcomes based on race, ethnicity, gender, and socioeconomic status.
Recent publications in 'JACC: Heart Failure' reveal several emerging themes that reflect the evolving landscape of heart failure research, focusing on innovative approaches, personalized medicine, and comprehensive care models.
  1. Digital Health and Telemedicine:
    A significant increase in studies exploring the use of digital health technologies, telemedicine, and remote patient monitoring for managing heart failure, especially post-COVID-19.
  2. SGLT2 Inhibitors and Heart Failure:
    Growing research interest in the application of SGLT2 inhibitors for heart failure management, highlighting their benefits beyond diabetes control and their impact on heart failure outcomes.
  3. Comorbid Conditions and Integrated Care:
    Emerging focus on the management of comorbidities alongside heart failure, particularly in relation to chronic kidney disease, obesity, and mental health, emphasizing a holistic approach to patient care.
  4. Health Equity and Social Determinants of Health:
    Increasing attention on health disparities and social determinants affecting heart failure outcomes, driving research that seeks to address inequities in access to care and treatment.
  5. Personalized Medicine Approaches:
    A trend towards personalized treatment strategies in heart failure, incorporating genetic, phenotypic, and biomarker data to tailor therapies to individual patient needs.

Declining or Waning

While 'JACC: Heart Failure' continues to thrive in many areas of research, certain themes are becoming less prominent in recent publications. These waning scopes reflect shifts in clinical focus and emerging evidence that may influence future research directions.
  1. Traditional Heart Failure Biomarkers:
    Research on conventional biomarkers like BNP and NT-proBNP is seeing a decline as newer, more comprehensive diagnostic approaches and biomarkers gain traction in heart failure management.
  2. Invasive Procedures for Diagnosis and Management:
    There is a noticeable decrease in studies centered on invasive procedures, such as routine cardiac biopsies or catheterizations, as non-invasive and remote monitoring technologies are increasingly preferred.
  3. Single-Factor Studies:
    Research focusing solely on single interventions or factors in heart failure is declining in favor of multi-faceted approaches that consider the complexity of patient care and the interaction of various treatment modalities.

Similar Journals

HEART & LUNG

Connecting Research and Practice in Critical Care
Publisher: MOSBY-ELSEVIERISSN: 0147-9563Frequency: 6 issues/year

HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

EUROPEAN JOURNAL OF HEART FAILURE

Shaping the future of cardiology with impactful discoveries.
Publisher: WILEYISSN: 1388-9842Frequency: 12 issues/year

The European Journal of Heart Failure, published by Wiley, is a premier international journal dedicated to advancing the field of cardiology, specifically focusing on heart failure research and clinical practices. With an impressive impact factor and ranked in the top 1% of journals in Cardiology and Cardiovascular Medicine according to Scopus rankings (Rank #7/387, Percentile 98th), this journal serves as a vital resource for researchers, clinicians, and students alike. Spanning from 1999 to 2024, the journal has established itself as a cornerstone for innovative research, comprehensive reviews, and clinical insights, fostering a deeper understanding of heart failure mechanisms, management, and treatment strategies. Although not an open-access journal, the European Journal of Heart Failure remains committed to disseminating high-quality, peer-reviewed content that contributes significantly to the global cardiovascular community. Located in the United States at 111 River St, Hoboken, NJ 07030-5774, it continues to play an essential role in shaping the future of heart failure management.

Cardiology Research and Practice

Pioneering discoveries in cardiovascular medicine.
Publisher: HINDAWI LTDISSN: 2090-8016Frequency: 1 issue/year

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.

Pakistan Heart Journal

Connecting Ideas, Transforming Cardiovascular Care.
Publisher: PAKISTAN CARDIAC SOCISSN: 0048-2706Frequency: 4 issues/year

Pakistan Heart Journal, with the ISSN 0048-2706 and E-ISSN 2227-9199, is a premier publication by the Pakistan Cardiac Society, dedicated to advancing the field of cardiology and cardiovascular medicine. Established as an Open Access journal since 2011, it provides a valuable platform for researchers and clinicians to disseminate innovative findings and insights within this critical area of health. Based in Karachi, Pakistan, at the National Institute of Cardiovascular Diseases, this journal aims to foster an enriched understanding of cardiovascular health by publishing rigorous research, case studies, and review articles. Despite its current categorization as Q4 in the latest 2023 quartiles and a rank of 357/387 in the Scopus database, it plays a vital role in the academic community, encouraging collaborative efforts and dialogue among professionals. The journal aspires to converge diverse perspectives and innovations in cardiology from 2019 to 2024, thereby enhancing the quality and scope of cardiovascular research in the region and beyond.

Journal of Cardiology

Advancing cardiovascular science for a healthier future.
Publisher: ELSEVIERISSN: 0914-5087Frequency: 12 issues/year

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.

CURRENT OPINION IN CARDIOLOGY

Empowering clinicians with the latest in cardiac research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0268-4705Frequency: 6 issues/year

CURRENT OPINION IN CARDIOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed journal in the field of cardiology that has been serving the academic community since 1988. With a robust focus on the latest developments and emerging trends in cardiovascular medicine, this journal aims to bridge the gap between clinical practice and research, offering critical insights and expert commentary. The journal is recognized in the medical community, achieving a 2023 Scopus rank of #148 out of 387 in its category, placing it in the 61st percentile. Although it operates under a subscription-based model, CURRENT OPINION IN CARDIOLOGY remains an essential resource for researchers, practitioners, and students seeking cutting-edge knowledge and advancements in cardiology. As a Q2 journal in the field, it continues to foster dialogue and provide a platform for disseminating impactful cardiovascular research, ultimately contributing to improved patient outcomes and informed clinical decisions.

ESC Heart Failure

Empowering healthcare professionals with vital cardiovascular insights.
Publisher: WILEY PERIODICALS, INCISSN: 2055-5822Frequency: 6 issues/year

ESC Heart Failure is a premier academic journal dedicated to the field of cardiology, specifically focusing on heart failure and its management. Published by WILEY PERIODICALS, INC, this esteemed journal has been an open access publication since 2014, making cutting-edge research readily accessible to a global audience. With its impressive impact factor and recent classification as a Q1 journal in Cardiology and Cardiovascular Medicine for 2023, ESC Heart Failure stands out as a leading resource with a Scopus ranking of #68 out of 387 in its field, placing it in the 82nd percentile. The journal aims to disseminate vital research findings, reviews, and clinical insights that advance the understanding and treatment of heart failure, thereby supporting healthcare professionals, researchers, and students in enhancing patient care. Its commitment to quality and relevance makes ESC Heart Failure an essential publication for anyone involved in cardiovascular medicine.

Circulation-Heart Failure

Fostering excellence in heart health scholarship.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1941-3289Frequency: 12 issues/year

Welcome to Circulation-Heart Failure, a leading peer-reviewed journal published by Lippincott Williams & Wilkins dedicated to advancing the field of cardiac biology and clinical cardiology. With an impressive impact factor and ranked in the Q1 category both in Cardiology and Cardiovascular Medicine and in Medicine (miscellaneous), this journal stands out as a vital resource for researchers, clinicians, and students. Since its inception in 2008, Circulation-Heart Failure has been at the forefront of disseminating innovative research, expert reviews, and clinical practices related to heart failure and cardiovascular health. The journal, housed in the United States, is committed to fostering a deeper understanding of heart failure management, offering regular issues that converge comprehensive studies, cutting-edge clinical insights, and the latest advancements in therapeutic strategies. Engage with the latest findings and contribute to the dialogue in a journal recognized for its rigorous standards and significant contributions to the cardiology community.

American Heart Journal Plus: Cardiology Research and Practice

Transforming Cardiology with Accessible Knowledge
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

American Heart Journal Plus: Cardiology Research and Practice, published by Elsevier, is a prominent open-access platform dedicated to advancing knowledge in the field of cardiology. With an evolving ISSN of 2666-6022, this journal serves as a vital resource for cardiologists, researchers, and healthcare professionals, contributing to the ever-growing discourse surrounding cardiovascular health. With a mission to disseminate high-quality research and innovative practices from 2021 to 2024, it aims to bridge the gap between scientific research and clinical application. Though currently ranked #264 out of 387 in the medicine category for cardiology and cardiovascular medicine, its commitment to quality and accessibility exemplifies the journal's importance in fostering collaboration and knowledge sharing within the medical community. Researchers are encouraged to take advantage of its open-access model to ensure that groundbreaking developments in cardiology are readily available to all stakeholders in the field.

International Journal of Angiology

Bridging gaps in angiology through impactful research and dialogue.
Publisher: THIEME MEDICAL PUBL INCISSN: 1061-1711Frequency: 4 issues/year

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.